Successful use of rasagiline in combination with two antidepressants: A case report

Narpinder Kaur, Rohit Madan, Ashish Sharma

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Parkinson's disease is the second most common neurodegenerative disorder, affecting 1 to 2 percent of people older than 60 years. Recent reviews show that depression is a common and potentially debilitating aspect of Parkinson's disease, affecting 40 to 50 percent of patients. Depression in Parkinson's disease is demonstrably different from ordinary major depression in terms of gender ratio, age, symptom profile, comorbidity, and chronicity. Pharmacotherapy for depression in Parkinson's disease entails special concerns related to side effects and drug-drug interactions. Rasagiline is a novel, potent, and irreversible monoamine oxidase type B (MAO-B) inhibitor that has recently been approved by the Food and Drug Administration for treatment of Parkinson's disease. Current rasagiline labeling advises the avoidance of coadministration of rasagiline and antidepressants, which is a challenge in itself for patients with co-morbid depression. We present a case of a 58-year-old woman who failed most of the pharmacologic treatments for Parkinson's disease, including deep brain stimulation, and was recently prescribed rasagiline with good response. She also met the Diagnostic and Statistical Manual, Fourth Edition, Text Revision criteria of major depressive disorder, which was treated with venlafaxine and bupropion. To our knowledge, this is first clinical case report of successful use of a combination of antidepressants and rasagiline in a patient with Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)39-41
Number of pages3
JournalInnovations in Clinical Neuroscience
Issue number11-12
StatePublished - Dec 2012


  • Bupropion
  • Depression
  • Parkinson's disease
  • Rasagiline
  • Venlafaxine

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Successful use of rasagiline in combination with two antidepressants: A case report'. Together they form a unique fingerprint.

Cite this